Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-10-014092
Filing Date
2010-02-18
Accepted
2010-02-18 15:30:35
Documents
15
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K c96467e10vk.htm 10-K 1260308
2 EXHIBIT 3.2 c96467exv3w2.htm EX-3.2 1477
3 EXHIBIT 21.1 c96467exv21w1.htm EX-21.1 20889
4 EXHIBIT 23.1 c96467exv23w1.htm EX-23.1 2816
5 EXHIBIT 31.1 c96467exv31w1.htm EX-31.1 5872
6 EXHIBIT 31.2 c96467exv31w2.htm EX-31.2 5889
7 EXHIBIT 32.1 c96467exv32w1.htm EX-32.1 2318
8 EXHIBIT 32.2 c96467exv32w2.htm EX-32.2 2331
15 GRAPHIC c96467c9646701.gif GRAPHIC 19165
  Complete submission text file 0000950123-10-014092.txt   4190566

Data Files

Seq Description Document Type Size
9 EX-101 INSTANCE DOCUMENT celg-20091231.xml EX-101.INS 802331
10 EX-101 SCHEMA DOCUMENT celg-20091231.xsd EX-101.SCH 21022
11 EX-101 CALCULATION LINKBASE DOCUMENT celg-20091231_cal.xml EX-101.CAL 52856
12 EX-101 LABELS LINKBASE DOCUMENT celg-20091231_lab.xml EX-101.LAB 199745
13 EX-101 PRESENTATION LINKBASE DOCUMENT celg-20091231_pre.xml EX-101.PRE 117554
14 EX-101 DEFINITION LINKBASE DOCUMENT celg-20091231_def.xml EX-101.DEF 20891
Mailing Address 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address 86 MORRIS AVENUE SUMMIT NJ 07901 (908)673-9000
CELGENE CORP /DE/ (Filer) CIK: 0000816284 (see all company filings)

EIN.: 222711928 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-16132 | Film No.: 10616105
SIC: 2834 Pharmaceutical Preparations